Meridian BioScience

Smaller device makers put in a muted performance

Mid- and small-cap medtechs find themselves at the mercy of government responses to the Covid-19 pandemic.

January 08, 2020

2019 was all about execution for smaller device makers

New products and strategic execution buoyed mid and small-cap medtechs, while safety worries took down one former high-flier.

January 10, 2018

Smaller medtechs soar in ’17 but could now be too expensive

Many small groups are up thanks to takeover speculation, and this may end up being self-defeating.

July 10, 2014

Smaller companies swirl in the wake of medtech megamergers